Screener
USANA Health Sciences USNA Rise — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
FAQ
- What is USANA Health Sciences's rise — D&A?
- USANA Health Sciences (USNA) reported rise — D&A of $211K in Q1 2026.
- What does rise — D&A mean?
- The total non-cash expense related to the wear and tear of physical assets and the amortization of intangible assets specifically utilized by the Rise segment. This metric is essential for understanding the capital intensity and asset consumption required to maintain the segment's operations.
Ask your AI about USANA Health Sciences's rise — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude